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Coronary artery diseaseAtherosclerosis is a complex disease, involving both genetic and environmental factors. However, the inﬂuence of
genetic variations on its early development remains unclear. This study examined the association of 12 different
polymorphismswith atherosclerosis severity in anterior descending coronary (DA, n=103) and carotid arteries
(CA, n= 66) of autopsied young adults (b30 years old). Histological sections (H-E) were classiﬁed according to
the American Heart Association. Polymorphisms in ACE, TNF-α (−308G/A and−238 G/A), IFN-γ (+874 A/T),
MMP-9 (−1562 C/T), IL-10 (−1082 A/G and−819 C/T), NOS3 (894 G/T), ApoA1 (rs964184), ApoE (E2E3E4
isoforms), and TGF-β (codons 25 and 10) genes were genotyped by gel electrophoresis or automatic DNA
sequencing. Firearm projectile or car accident was the main cause of death, and no information about classical
risk factors was available. Histological analysis showed high prevalence of type III atherosclerotic lesions in
both DA (69%) and CA (39%) arteries, while severe type IV and V lesions were observed in 14% (DA) and 33%
(CA). Allele frequencies and genotype distributions were determined. Among the polymorphisms studied,
IFN-γ and IL-10 (−1082 A/G) were related to atherosclerosis severity in DA artery. No association between
genotypes and lesion severity was found in CA. In conclusion, we observed that the high prevalence of early
atherosclerosis in young adults is associated with IFN-γ (p b 0.001) and IL-10 (p = 0.013) genotypes. This
association is blood vessel dependent. Our ﬁndings suggest that the vascular system presents site specialization,
and speciﬁc genetic variations may provide future biomarkers for early disease identiﬁcation.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Atherosclerosis is the common underlying mechanism of ischemic
heart disease and stroke, the worldwide leading mortality causes
(WHO, 2011). This multifocal vascular complex disease evolves from
interactions among various genetic and environmental factors [1].
Besides the classical risk factors for cardiovascular disease (e.g., hyper-
tension, cigarette smoking, diabetes, and overweight), abnormal lipid
metabolism, endothelial dysfunction, and inﬂammation are major
factors in the development of atherosclerotic lesions. Inﬂammationde, Instituto de Biofísica Carlos
v. Carlos Chagas Filho 373, Rm
razil. Tel.: +55 21 2564 7364;
. This is an open access article undermarkers are also identiﬁed as “emerging risk factors” for cardiovascular
disease [2].
Although atherosclerosis begins early in life, the clinicalmanifestation
of the disease appears only later. Early clinical manifestation represents
only 10% of the cases, but the prevalence of pre-clinic atherosclerotic
manifestation in young adults is much higher [3,4]. Advances in molecu-
lar genetics highlight the role of genetic polymorphisms in the disease
pathogenesis [1,5–11]. Previous studies report an association between
atherosclerosis severity in young adults, without classical risk factor for
coronary disease, and SNPs in genes related to lipid metabolism, as well
as in cytokine genes [4,12]. However, the contribution of genetic variation
to atherosclerosis remains unclear. We ponder that the young adult
population is an interesting group to study the inﬂuence of genetic
polymorphisms on atherosclerosis since they have been less exposed to
classical environmental risk factors in comparison to older adults. Thus,
the present study aimed to investigate the association between geneticthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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phisms in twelve protein-coding genes involved in different pathways
related to atherosclerosis pathogenesis were analyzed and correlated
with the presence and severity of atherosclerotic lesion in both coronary
and carotid arteries of autopsied young adults. Polymorphisms were
selected based on their involvement in injurymechanisms, such as angio-
tensin-converting enzyme (ACE), Th-1 and Th-2 inﬂammatory response
(TNF-α:−308G/A and−238 G/A, IFN-γ: +874 A/T, and IL-10:−1082
A/G and −819 C/T, respectively), vascular function and remodeling
(NOS3: 894 G/T, MMP-9: −1562 C/T, TGF-β codons 25 and 10), and
lipidmetabolism (ApoA1: rs964184, ApoE: E2E3E4 isoforms). The results
showed associations between IL-10 and IFN-γ genotypes with athero-
sclerotic lesion severity in coronary, but not in carotid arteries.
2. Materials and methods
2.1. Population
The population studied consisted of consecutive cases of individuals,
males and females, under 30 years of age who died of external causes
(accidents or homicides) andwere autopsied at Rio de Janeiro's Institute
of Legal Medical within 18 h after death. Age, skin color (rated as light,
intermediate or dark), and physical feature information were obtained
by direct observation of the body. Data from 122 cases, from which
the extraction of muscle DNA and histopathological evaluation of at
least one arterywere available, were analyzed. This studywas approved
by local Ethics Committee of the Instituto Médico Legal Afrânio Peixoto
(Rio de Janeiro, Brazil).
2.2. Arterial specimens
Segments of approximately 5 cm from anterior descending coronary
(DA, n = 103) and carotid (CA, n = 66) arteries were removed at
autopsy and ﬁxed with 10% buffered formaldehyde. Carotid artery
samples were obtained just below common carotid artery bifurcation.
Fragments of the ﬁxed tissues were embedded in parafﬁn, and 4-μm-
thick slices were stained with hematoxylin-eosin (H-E). Artery wall
morphology was examined in each sample at ×100 and ×400 magniﬁ-
cation on a conventional lightmicroscope (Axioplan, Zeiss, Oberkochen,
Germany). Samples were classiﬁed for atherosclerotic lesion severity
accordingly to the American Heart Association, where types I–VI are
characterized as follows: type I, isolated lipid containing macrophages
(foam cells), without extracellular lipid deposition; type II, multiple
foam cell layers; type III, isolated extracellular lipid pools; type IV,
conﬂuent extracellular lipid (core formation); type V, core with
ﬁbromuscular tissue production or calciﬁcation; type VI, plaque
with surface rupture, hematoma, or thrombosis [13,14]. TwoTable 1
Gene polymorphisms studied, primer sequences, and ampliﬁcation conditions.
Gene Chr SNPs Pair of prim
ACE 17 287 bp Ins/Del in intron 16 F: CTGGAGA
R:GATGTGG
TNF-α 6 −308G/A F: TCCTGCA
−238G/A R: AGGGAG
IFN-γ 12 +874A/T F: GGAACTT
R: CTATTAC
IL-10 1 −819 T/C (rs1800871) F: CTC GCT
−1082A/G (rs1800896) R: CCT AGG
MMP-9 20 −1562C/T F: AATGCCT
R: CTTTCTT
NOS3 7 +894G/T (rs1799983) F: AAGGCAG
R: CCCAGTC
ApoA1 11 G/C (rs964184) F: AGATACC
R: CAGCACT
ApoE 19 E2E3E4 isoforms TaqMan ass
TGF-β Codon 25 (G/C) F: GCCCTTC
Codon 10 (T/C) R: GGCGAGindependent observers made the histopathological analysis in a
blinded manner.
2.3. DNA extraction and genotyping
Skeletal muscle samples were collected at autopsy and stored
at−20 °C. Tissue samples were digested overnight in 0.2 μL proteinase
K buffer (20 mg/mL) at 37 °C followed by DNA extraction with phenol-
chloroform. After ethanol precipitation, DNA was collected, resuspend-
ed in distilled water (60 μL), and stored at −20 °C. The ﬁnal DNA
concentration was measured by spectrophotometry at 260 nm and
aliquoted at 200 ng/μL.
ACE (ins/del intron 16), IFN-γ (+874 T/A), TNF-α (−238 G/A
and −308 G/A), IL-10 (−819 C/T and −1082 A/G, rs1800871 and
rs1800896, respectively), MMP-9 (−1562 C/T), NOS3 (+894G/T,
rs1799983), ApoA1 (rs964184), and TGF-β (codon 25 and 10) gene
polymorphisms were genotyped by sequencing PCR products with
speciﬁc primers, as shown in Table 1. The ampliﬁed products were se-
quenced using the DYEnamicTM ET Dye Terminator Cycle Sequencing
kit for MegaBACE (Amersham Pharmacia Biotech Inc). ACE genotypes
were analyzed by agarose gel (1%) electrophoresis, where deleted
(D) and insertion (I) alleles were identiﬁed as 190 bp and 490 bp
fragment, respectively. ApoE genotyping (E2E3E4 isoforms) was
determined by 5′-nuclease assay and ﬂuorogenic allele-speciﬁc TaqMan
assay (TaqMan Pre-Designed SNP Genotyping Assays, cat no.
C3084793-20 and C904973-10, Applied Biosystems), following the
manufacturer's instructions and using the 7500 Real-Time PCR (Applied
Biosystems, USA). Sequencing analysis was performed using Geneious
4.7.5 (Biomatters, http://www.geneious.com).
2.4. Statistical analysis
The SPSS v15 statistical software package (Chicago, IL, USA) was
used. The chi-square or Fisher's exact method was used to determine
deviations from Hardy–Weinberg equilibrium and to investigate possi-
ble association between genotype or allele frequencies and histological
atherosclerotic lesion severity. In all instances, the signiﬁcance levelwas
set at 5% (p b 0.05).
3. Results
The population characteristics are shown in Table 2. Population
mean age was 22 ± 5.4 years old [112 males (92%) and 10 females],
and the causa mortis mainly resulted from ﬁrearm projectile. Ninety
three percent of subjects had normal or low body weight.
The severity of atherosclerotic lesions was assessed by H-E histolog-
ical analysis that showed high prevalence of atherosclerotic lesions iners (5′–3′) PCR conditions
CCACTCCCATCCTTTCT 94 °C—1 m (30 cycles), 58 °C—1 m, 72 °C—2 m
CCATCACATTCGTCAGA
TCCTGTCTGGAAGT 94 °C—30 s (35 cycles), 60 °C—45 s, 72 °C—1 m
CGTCTGCTGGCTGGGTG
CGTTGCTCACTGGG 94 °C—30 s (35 cycles), 58 °C—45 s, 72 °C—1 m
ATCTACTGTGC CTTCCTG
GCA ACC CAA CTG GC 94 °C—30 s (35 cycles), 55 °C—45 s, 72 °C—1 m
TCA CAG TGA CGT GG
GGCACATAGTAGGCCCT 95 °C—1 m (35 cycles), 62 °C—1 m, 72 °C—1 m
CCTAGCCAGCCGGCATC
GAGACAGTGGATGGA 94 °C—30 s (30 cycles), 60 °C—45 s, 72 °C—30 s
AATCCCTTTGGTGCTCA
CACACAGCTCACTCCC 94 °C—30 s (30 cycles), 60 °C—45 s, 72 °C—30 s
GGCCTCTGTATTGACC
ay
TCCCTGAGGACCTC 94 °C—30 s (30 cycles), 60 °C—45 s, 72 °C—1 m
CCGCAGCTTGGACAG
Table 2
Population characteristics.
Characteristic Number of cases (%)
Mean age 22 ± 5.4 years
Gender
Male 112 (92%)
Female 10 (8%)
Physical constitution
Slim 40 (33%)
Regular 71 (58%)
Obese 11 (9%)
Skin color
Light 28 (23%)
Dark 30 (25%)
Intermediate 64 (52%)
Fig. 2. Histological classiﬁcation [according to the American Heart Association (AHA)] of
atherosclerotic lesions in anterior descending coronary (DA) and carotid (CA) arteries
from autopsied cases of young adults.
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classiﬁed as normal, respectively (Figs. 1 and 2). Despite a young age
population, we observed severe atherosclerotic lesions (types IV and
V) in 14% and 33% of DA and CA arteries, respectively.
Table 3 shows the allele frequencies for the genotypes studied. No
deviation from Hardy–Weinberg equilibrium was observed. Tables 4
and 5 depict the distribution and association of genotypes with severity
of histologic atherosclerosis in coronary and carotid arteries, respectively.
Lesion severity in coronary arteries was associated with polymorphisms
of IL-10 (−1082 A/G) and IFN-γ (+874 T/A) (Tables 4 and 5, respective-
ly). On the contrary, no association between genotypes and lesion sever-
ity was observed for carotid arteries.
IL-10 levels are inﬂuenced by three single nucleotide polymorphisms
(SNPs:−1082 A/G,−819 C/T and−592 C/A) of the corresponding gene,
originating three haplotypes (GCC, ACC, and ATA). Based on these
haplotypes, individuals are classiﬁed as follows: high IL-10
producers (GCC/GCC), intermediate (GCC/ACC, GCC/ATA), and low
producers (ACC/ACC, ACC/ATA, and ATA/ATA). In our sample, IL-10
−1082 G/A and−819 C/T genotypes were found in 48 and 50 cases,Fig. 1. Photomicrographs representative of atherosclerotic lesion in anterior descending corona
sion, with foam cell deposition (arrow) and extracellular lipid pools (arrowhead), HE ×40 mag
eroma plaque (HE ×10 magniﬁcation). (C) type IV lesion, note intact epithelium, and well-deﬁrespectively. We determined−592 C/A genotype from the−819 C/T,
since they occur in linkage disequilibrium [12]. We determined IL-10
haplotype (−1082 A/G,−819 C/T and−592 C/A) in 42 individuals. Of
these, 5 (12%) presented haplotypes associated with high IL-10 levels, 9
(21%)with intermediate and 29 (67%)with low IL-10 levels. The distribu-
tion and frequency of IL-10 genotypes and haplotypes are shown in
Table 6. Althoughwe did notﬁnd any association in carotid arteries, allele
A at position−1082 of the IL-10 gene was highly prevalent in autopsy
cases with atherosclerotic lesion types III and IV.
4. Discussion
Atherosclerosis is a complex disease, resulting from both environ-
mental and genetic factors. Although clinical manifestations appear
after the ﬁfth decade, the atherosclerotic process begins early in life.
While early onset can account for 10% of the cases, pre-clinicalry (A, B) and carotid (C) arteries of autopsied young adults. (A) Type III atherosclerotic le-
niﬁcation. (B) Type V lesion, arrow shows vessel lumen partially occluded by ﬁbrotic ath-
ned necrotic core (asterisk) with cholesterol crystals (arrow), HE ×10 magniﬁcation.
Table 3
Allele frequencies (f) for studied genotypes in 122 autopsied young adults.
SNP Allele All subjects
(f)
DA group
(f)
CA group
(f)
ACE (ins/del intron 16) (n= 120) D 0.604 0.636 0.594
I 0.396 0.374 0.406
TNF-α (−238 G/A) (n= 94) G 0.953 0.956 0.938
A 0.047 0.044 0.063
TNF-α (−308 G/A) (n= 95) G 0.787 0.791 0.787
A 0.213 0.209 0.213
IFN-γ (+874 T/A) (n= 111) A 0.757 0.763 0.712
T 0.243 0.237 0.288
MMP-9 (−1562 C/T) (n= 68) C 0.868 0.871 0.883
T 0.132 0.129 0.117
IL-10 (−1082 A/G) (n= 48) A 0.760 0.750 0.929
G 0.240 0.250 0.071
IL-10 (−819 C/T) (n= 50) T 0.380 0.411 0.375
C 0.620 0.589 0.625
NOS3 (rs1799983) (n= 112) G 0.795 0.814 0.784
T 0.205 0.186 0.216
ApoA1 (rs964184) (n= 112) C 0.843 0.793 0.817
G 0.157 0.207 0.183
TGF-β (codon 25) (n= 111) G 0.941 0.935 0.957
C 0.059 0.065 0.043
TGF-β (codon 10) (n= 111) T 0.559 0.543 0.612
C 0.441 0.457 0.388
217J.C.P. Esperança et al. / BBA Clinical 3 (2015) 214–220atherosclerotic manifestations in young adults is much higher [3,4]. The
early appearance of arterial lesion may constitute the morphological
manifestation of the genetic component of the disease. With this in
mind, we reasoned that the young adult population is an interestingTable 4
Association between genotype frequencies and atherosclerotic lesion severity in descendent co
SNP Genotype Atherosclerotic lesion in de
Normal I
ACE (ins/del intron 16) (n= 103) DD 0.010 0.000
DI 0.000 0.000
II 0.010 0.000
TNF-α (−238 G/A) (n= 80) GG 0.013 0.000
GA 0.000 0.000
AA 0.000 0.000
TNF-α (−308 G/A) (n= 79) GG 0.013 0.000
GA 0.000 0.000
AA 0.000 0.000
IFN-γ (+874 T/A) (n= 98) AA 0.020 0.000
AT 0.000 0.000
TT 0.000 0.000
MMP-9 (−1562 C/T) (n= 58) CC 0.000 0.000
CT 0.000 0.000
TT 0.000 0.000
IL-10 (−1082 A/G) (n= 43) GG 0.023 0.000
GA 0.000 0.000
AA 0.000 0.000
IL-10 (−819 C/T) (n= 48) TT 0.000 0.000
TC 0.000 0.000
CC 0.000 0.000
NOS3 (rs1799983) (n= 94) GG 0.011 0.000
GT 0.011 0.000
TT 0.000 0.000
ApoA1 (rs964184) (n= 94) CC 0.021 0.000
CG 0.000 0.000
GG 0.000 0.000
ApoE (E2E3E4 isoforms) (n= 100) E3E3 0.010 0.000
E3E4 0.010 0.000
E2E3 0.000 0.000
E2E4 0.000 0.000
E4E4 0.000 0.000
TGF-β (codon 25) (n= 92) GG 0.011 0.000
GC 0.000 0.000
CC 0.000 0.000
TGF-β (codon 10) (n= 92) TT 0.000 0.000
TC 0.011 0.000
CCgroup to study the inﬂuence of genetic polymorphismson atherosclerosis
since they have been less exposed to classical risk factors than older
adults. In this way, polymorphisms in twelve protein-coding genes in-
volved in different pathways related to atherosclerosis pathogenesis
were established. The results showed a high prevalence of atherosclerotic
lesions type III in coronary and carotid arteries of autopsied young adults.
Also, most severe lesions (types IV and V) were observed in 14% and 33%
of DA and CA arteries, respectively. Furthermore, the degree of athero-
sclerotic lesion severity was associated with genetic polymorphisms in
IL-10 and IFN-γ genes at coronary, but not at carotid artery.
Our data support the knowledge of atherosclerosis as an early-onset
diffuse disease. The great majority of the autopsied cases resulted from
deaths secondary to external causes, e.g., car accidents orﬁrearmprojec-
tiles. Only obesity could be discarded as classical risk factor in this
population, since 93% of the subjects were normal or slim. Although
no previous clinical information was available, epidemiological reports
show low prevalence of clinical atherosclerotic manifestations under
30 years of age [3,4]. Additionally, histopathological studies suggest
that lesion types I–III are usually clinically silent [15]. Clinicalmanifesta-
tions are associated with atherosclerotic lesions under type VI. Howev-
er, lesions types IV–VImay remain silent. It is noteworthy that our study
presents some limitations since individual characteristics, such as diet,
body mass index, precise age and classical atherosclerotic risk factors
(e.g., hypertension, cigarette smoking, diabetes, and cholesterol levels),
were not available. This lack of information prevented the use of multi-
ple regression analysis with adjusted model for individual characteris-
tics. Furthermore, we cannot rule out the use of recreational drugs and
the role of stress on atherosclerotic lesion in this population.ronary artery of autopsied young adults.
scendent anterior coronary artery (AHA classiﬁcation) p (χ2 test)
II III IV V VI
0.058 0.282 0.019 0.049 0.000
0.078 0.291 0.039 0.010 0.000
0.019 0.117 0.000 0.019 0.000 0.48
0.138 0.663 0.063 0.063 0.000
0.000 0.038 0.000 0.000 0.000
0.000 0.025 0.000 0.000 0.000 0.98
0.076 0.494 0.038 0.051 0.000
0.051 0.165 0.013 0.013 0.000
0.013 0.063 0.013 0.000 0.000 0.94
0.041 0.439 0.041 0.051 0.000
0.112 0.204 0.010 0.000 0.000
0.010 0.051 0.000 0.020 0.000 0.0001*
0.138 0.500 0.069 0.069 0.000
0.034 0.121 0.034 0.000 0.000
0.000 0.034 0.000 0.000 0.000 0.83
0.047 0.047 0.023 0.023 0.000
0.000 0.163 0.000 0.047 0.000
0.163 0.442 0.023 0.000 0.000 0.013*
0.089 0.222 0.000 0.000 0.000
0.044 0.133 0.022 0.000 0.000
0.089 0.333 0.022 0.044 0.000 0.67
0.096 0.447 0.021 0.053 0.000
0.074 0.223 0.043 0.021 0.000
0.000 0.000 0.000 0.000 0.000 0.51
0.085 0.383 0.043 0.053 0.000
0.064 0.309 0.021 0.021 0.000
0.000 0.000 0.000 0.000 0.000 0.67
0.070 0.420 0.030 0.030 0.000
0.050 0.190 0.030 0.020 0.000
0.040 0.060 0.000 0.020 0.000
0.000 0.010 0.000 0.000 0.000
0.000 0.010 0.000 0.000 0.000 0.93
0.163 0.587 0.054 0.065 0.000
0.000 0.098 0.011 0.000 0.000
0.000 0.011 0.000 0.000 0.000 0.46
0.054 0.196 0.011 0.032 0.000
0.065 0.359 0.033 0.033 0.000 0.80
Table 5
Association between genotype frequencies and atherosclerotic lesion severity in carotid artery of autopsied young adults.
SNP Genotype Atherosclerotic lesion in carotid artery (AHA classiﬁcation) p (χ2 test)
Normal I II III IV V VI
ACE (ins/del intron 16) (n= 64) DD 0.000 0.016 0.125 0.141 0.109 0.000 0.000
DI 0.000 0.047 0.047 0.156 0.141 0.016 0.000
II 0.000 0.016 0.016 0.094 0.047 0.031 0.000 0.27
TNF-α (−238 G/A) (n= 48) GG 0.000 0.063 0.208 0.292 0.313 0.042 0.000
GA 0.000 0.000 0.000 0.042 0.000 0.000 0.000
AA 0.000 0.021 0.000 0.021 0.000 0.000 0.000 0.30
TNF-α (−308 G/A) (n= 47) GG 0.000 0.085 0.170 0.213 0.149 0.043 0.000
GA 0.000 0.000 0.021 0.106 0.128 0.000 0.000
AA 0.000 0.000 0.000 0.043 0.043 0.000 0.000 0.41
IFN-γ (+874 T/A) (n= 60) AA 0.000 0.083 0.067 0.217 0.150 0.033 0.000
AT 0.000 0.000 0.083 0.150 0.100 0.000 0.000
TT 0.000 0.000 0.017 0.033 0.050 0.017 0.000 0.39
MMP-9 (−1562 C/T) (n= 32) CC 0.000 0.000 0.094 0.313 0.250 0.063 0.000
CT 0.000 0.063 0.063 0.063 0.063 0.031 0.000
TT 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.06
IL-10 (−1082 A/G) (n= 21) GG 0.000 0.000 0.000 0.000 0.000 0.000 0.000
GA 0.000 0.048 0.000 0.048 0.000 0.048 0.000
AA 0.000 0.095 0.143 0.286 0.333 0.000 0.000 0.07
IL-10 (−819 C/T) (n= 20) TT 0.000 0.000 0.050 0.050 0.150 0.000 0.000
TC 0.000 0.050 0.050 0.100 0.050 0.000 0.000
CC 0.000 0.100 0.050 0.200 0.100 0.050 0.000 0.78
NOS3 (rs1799983) (n= 59) GG 0.000 0.068 0.102 0.237 0.119 0.051 0.000
GT 0.000 0.017 0.085 0.153 0.153 0.000 0.000
TT 0.000 0.000 0.000 0.017 0.000 0.000 0.000 0.62
ApoA1 (rs964184) (n= 60) CC 0.017 0.050 0.117 0.250 0.167 0.033 0.000
CG 0.000 0.033 0.050 0.133 0.133 0.017 0.000
GG 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.93
ApoE (E2E3E4 isoforms) (n= 100) E3E3 0.000 0.045 0.152 0.212 0.242 0.000 0.000
E3E4 0.000 0.015 0.030 0.121 0.030 0.030 0.000
E2E3 0.015 0.000 0.000 0.030 0.015 0.015 0.000
E2E4 0.000 0.000 0.000 0.000 0.000 0.000 0.000
E4E4 0.000 0.015 0.000 0.030 0.000 0.000 0.000 0.12
TGF-β (codon 25) (n= 58) GG 0.017 0.069 0.098 0.228 0.163 0.033 0.000
GC 0.000 0.000 0.017 0.034 0.034 0.000 0.000
CC 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.96
TGF-β (codon 10) (n= 58) TT 0.017 0.034 0.086 0.138 0.069 0.034 0.000
TC 0.000 0.017 0.069 0.190 0.172 0.017 0.000
CC 0.000 0.017 0.017 0.069 0.051 0.000 0.000 0.76
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environmental factors than older individuals due to the shorter expo-
sure time to the classical risk factors. Since this is usually an asymptom-
atic group, investigation, direct observation, or conﬁrmation of
atherosclerotic lesion is less frequent. During the time of sample collec-
tion for this study, urban violence rate in Rio de Janeiro was high. This
has allowed us to access a particular informative material, e.g., arterial
segments of young adults under 30 years of age, which may yield aTable 6
Distributions and frequencies of IL-10 genotypes and haplotypes in all subjects and in
anterior descendent coronary artery (DA) and carotid artery (CA) groups.
Genetic markers All subjects DA group CA group
Genotypes, n (%)
GCC/GCC 5 (12) 5 (13) 0 (0)
GCC/ACC 8 (19) 7 (18) 3 (17)
GCC/ATA 1 (2) 1 (3) 0 (0)
ACC/ACC 10 (24) 7 (18) 6 (33)
ACC/ATA 8 (19) 7 (18) 5 (28)
ATA/ATA 11 (26) 10 (26) 4 (22)
Haplotype carrier rate, n (%)
GCC 14 (33) 13 (35) 3 (17)
ACC 26 (61) 21 (57) 14 (78)
ATA 20 (47) 18 (49) 9 (50)
Haplotype frequency
GCC 0.221 0.243 0.083
ACC 0.326 0.378 0.556
ATA 0.360 0.378 0.361gold standard parameter for correlation analysis studies. This group
can be of particular interest for better understanding the inﬂuence of
genetic variants on atherosclerosis in our population.
We observed type II atherosclerotic lesion (fatty streaks) in 22% of
individuals. This prevalence is much lower than the one reported in
the large PDAY study involving North American young adults, where
type II lesionwas observed in almost all individuals [16]. This discrepan-
cy can be explained by the histopathological technique used,whichmay
have underscored unanalyzed regions [17]. On the other hand, it should
be pointed out thatwe found high prevalence of type III lesions (intimal
thickening with extracellular lipid deposition), 69% for DA and 39% for
CA. These ﬁndings support previous report in coronary and aortic
arteries in young adults from India [18]. Such a high prevalence of
type III lesion in our study is of particular relevance since this lesion is
considered irreversible, as well as precursor of more severe arterial
involvement [1,19,20]. Furthermore, severe type IV and even V lesions
were also observed (14% in DA and 33% in CA). This prevalence is some-
what higher than previously reported in North American young adults
[2,16], but close to that observed in young adults from India [3,4,18].
Since these severe atherosclerotic lesions are associated with clinical
manifestations and complications [1,5–11,15], their presence in our
study call our attention for the need of better understanding the inﬂu-
ence of genetic variants in our young population and the early-onset
atherosclerotic process.
In the present study, a group of SNPswas selected based on their role
in different molecular pathways related to the atherosclerotic process,
such as lipid metabolism (ApoA1 and ApoE), Th-1 (IFN-γ and TNF-α)
and Th-2 inﬂammatory responses (IL-10), and endothelial function
219J.C.P. Esperança et al. / BBA Clinical 3 (2015) 214–220and vascular remodeling (ACE, NOS3,MMP-9, and TGF-β). Note that the
genes selected and their SNPs have been associated with either cardio-
vascular risk or the evolution of the disease itself [4,12]. In this study,we
found correlation between IFN-γ and IL-10 gene variants and severity of
histopathologic atherosclerosis lesion. We did not ﬁnd any correlation
for polymorphisms on ACE, ApoA1, ApoE, NOS3, MMP-9, TNF-α, or
TGF-β genes. Previous study showed a role for VEGF, IL-10, and IFN-γ
gene variants in the genetic background of offspring of parents with
premature acute myocardial infarction [13,14,21]. Our results conﬁrm
and expand these ﬁndings since SNPs in the IL-10 and IFN-γ genes, in-
volved in the inﬂammatory response, are related to the early-onset of
histopathological vascular lesions in a random population, indepen-
dently of parental history. The distribution of genotype frequencies ob-
served in this study is in agreement with previous reports in the
Brazilian population [22,23].
Data from human and animal studies show a predominant Th-1
pattern in atherosclerosis. The major pro-atherogenic Th-1 cytokine,
IFN-γ, promotes macrophage and endothelial activation, leading to
production of adhesionmolecules, cytokines, chemokines, radicals, pro-
teases, and coagulation factors. The targeted deletion of IFN-γ reduces
atherosclerotic disease, whereas its administration accelerates lesion
development in mice [2,12]. Furthermore, previous study reports
IFN-γ variant association with high producer genotype [3–5]. Our data
corroborate these ﬁndings that ascribe a role for Th-1 inﬂammatory
response in the atherosclerosis process development.
In contrast to IFN-γ, data on the role of IL-10 in atherosclerosis are
more controversial. IL-10 has both inﬂammatory and anti-inﬂammatory
functions, and 75% of its variation production is genetically determined
[3,4,24]. Three SNPs at positions −1082, −819, and −592 of IL-10
gene form three haplotypes (GCC, ACC, and ATA) associated with high
(GCC/GCC), intermediate (GCC/ACC, GCC/ATA), and low (ATA/ATA,
ACC/ATA, ACC/ACC) IL-10 production [15,25–27]. Although previous
studies suggest atheroprotective effects for IL-10 [16,28–30], most of
the data on humans are based on middle-aged or older subjects. In such
populations, the genetic contribution may be masked by the strong
covariates, such as the conventional risk factors [12,17,31]. On the other
hand, one study [12,18] on young subjects reported association of IL-10
high and intermediate producers with decreased arterial elasticity, even
after adjustment for conventional risk factors. Our data on autopsy
cases of young adults showed a high frequency of low IL-10 producer
genotype, highlighting the importance of studying young individuals in
order to better observe the contributionof genetic diversity to the athero-
sclerotic process. Furthermore, this autopsy study allowed us to produce
a morphological gold standard parameter of the initial atherosclerotic
lesions in young adults, as well as its relation with the genetic diversity
of the population.
Finally, it should be kept in mind that the inﬂuence of genetic
polymorphisms on atherosclerosis in young adults, as observed by the
associations between IL-10 and IFN-γ SNPs with lesion severity, was
found only for coronary, but not for carotid artery. These ﬁndings sup-
port the hypothesis that the vascular system presents site specialization
[32], which may differentially inﬂuence atherosclerosis development.
The better understanding of genetic inﬂuence on the atherosclerosis
process can provide future biomarkers for early-onset identiﬁcation of
the disease, thus improving its prevention and management, which
can reduce the disease morbimortality.
Conﬂict of interest
The authors declare that they have no conﬂict of interest.
Transparency document
The Transparency document associated with this article can be
found, in the online version.Acknowledgments
We would like to express our gratitude to Elizabeth Valentin, César
Félix Schmidt, Jorge Luiz Albuquerque Coutinho, and Cláudio Nunes
Pereira for their technical assistance. This study was supported
by Conselho Nacional de Desenvolvimento Cientíﬁco e Tecnológico
(CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
(CAPES), Fundação Carlos Chagas Filhode Apoio à Pesquisa do Estado do
Rio de Janeiro (FAPERJ), and Instituto Nacional de Cardiologia (INC),
Brazil.References
[1] H. Roy, S. Bhardwaj, S. Ylä-Herttuala, Molecular genetics of atherosclerosis, Hum.
Genet. 125 (2009) 467–491. http://dx.doi.org/10.1007/s00439-009-0654-5.
[2] Hansson, Inﬂamm. Atheroscler. (2010) 1–35.
[3] J.E. Hixson, Apolipoprotein E polymorphisms affect atherosclerosis in young males.
Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group,
Arterioscler. Thromb. 11 (1991) 1237–1244.
[4] S. Okser, T. Lehtimäki, L.L. Elo, N. Mononen, N. Peltonen, M. Kähönen, et al., Genetic
variants and their interactions in the prediction of increased pre-clinical carotid
atherosclerosis: the cardiovascular risk in young Finns study, PLoS Genet. 6 (2010)
e1001146. http://dx.doi.org/10.1371/journal.pgen.1001146.t004.
[5] V. Pravica, C. Perrey, A. Stevens, J.H. Lee, I.V. Hutchinson, A single nucleotide
polymorphism in the ﬁrst intron of the human IFN-gamma gene: absolute correla-
tion with a polymorphic CA microsatellite marker of high IFN-gamma production,
Hum. Immunol. 61 (2000) 863–866.
[6] T.A. Manolio, Genetics of ultrasonographic carotid atherosclerosis, Arterioscler.
Thromb. Vasc. Biol. 24 (2004) 1567–1577.
[7] S.C. Sookoian, C. González, C.J. Pirola, Meta-analysis on the G-308A tumor necrosis
factor alpha gene variant and phenotypes associated with the metabolic syndrome,
Obes. Res. 13 (2005) 2122–2131. http://dx.doi.org/10.1038/oby.2005.263.
[8] S. Abilleira, S. Bevan, H.S. Markus, The role of genetic variants of matrix metallopro-
teinases in coronary and carotid atherosclerosis, J. Med. Genet. 43 (2006) 897–901.
http://dx.doi.org/10.1136/jmg.2006.040808.
[9] R.C. Kaplan, N.L. Smith, S. Zucker, S.R. Heckbert, K. Rice, B.M. Psaty, Matrix
metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction,
ischemic stroke, and hemorrhagic stroke, Atherosclerosis 201 (2008) 130–137.
http://dx.doi.org/10.1016/j.atherosclerosis.2008.01.003.
[10] J.W. Knowles, T.L. Assimes, E. Boerwinkle, S.P. Fortmann, A. Go, M.L. Grove, et al.,
Failure to replicate an association of SNPs in the oxidized LDL receptor gene
(OLR1) with CAD, BMC Med. Genet. 9 (2008) 23. http://dx.doi.org/10.1186/1471-
2350-9-23.
[11] T. Angeline, W. Isabel, G.J. Tsongalis, Endothelial nitric oxide gene polymorphisms,
nitric oxide production and coronary artery disease risk in a South Indian popula-
tion, Exp. Mol. Pathol. 1–16 (2010)http://dx.doi.org/10.1016/j.yexmp.2010.08.009.
[12] M. Heiskanen, M. Kähönen, M. Hurme, T. Lehtimäki, N. Mononen, M. Juonala, et al.,
Polymorphism in the IL10 promoter region and earlymarkers of atherosclerosis: the
Cardiovascular Risk in Young Finns Study, Atherosclerosis 208 (2010) 190–196.
http://dx.doi.org/10.1016/j.atherosclerosis.2009.06.032.
[13] H.C. Stary, A.B. Chandler, S. Glagov, J.R. Guyton, W. Insull, M.E. Rosenfeld, et al., A
deﬁnition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report
from the Committee on Vascular Lesions of the Council on Arteriosclerosis,
American Heart Association, Circulation 89 (1994) 2462–2478.
[14] H.C. Stary, A.B. Chandler, R.E. Dinsmore, V. Fuster, S. Glagov, W. Insull, et al., A
deﬁnition of advanced types of atherosclerotic lesions and a histological classiﬁcation
of atherosclerosis. A report from the Committee on Vascular Lesions of the Council
on Arteriosclerosis, Am. Heart Assoc. Arterioscler. Thromb. Vasc. Biol. 15 (1995)
1512–1531.
[15] H.C. Stary, Natural history and histological classiﬁcation of atherosclerotic lesions:
an update, Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1177–1178. http://dx.doi.
org/10.1161/01.ATV.20.5.1177.
[16] N. Fausto, Atherosclerosis in young people: the value of the autopsy for studies of
the epidemiology and pathobiology of disease, Am. J. Pathol. 153 (1998)
1021–1022. http://dx.doi.org/10.1016/S0002-9440(10)65646-5.
[17] R.W.Wissler, USAMulticenter Study of the pathobiology of atherosclerosis in youth,
Ann. N. Y. Acad. Sci. 623 (1991) 26–39.
[18] M.J. Thej, R. Kalyani, J. Kiran, Atherosclerosis in coronary artery and aorta in a semi-
urban population by applying modiﬁed American Heart Association classiﬁcation of
atherosclerosis: an autopsy study, J. Cardiovasc. Dis. Res. 3 (2012) 265–271. http://
dx.doi.org/10.4103/0975-3583.102692.
[19] K. Sakakura, M. Nakano, F. Otsuka, E. Ladich, F.D. Kolodgie, R. Virmani, Pathophysiol-
ogy of atherosclerosis plaque progression, Heart Lung Circ. 22 (2013) 399–411.
http://dx.doi.org/10.1016/j.hlc.2013.03.001.
[20] H.C. McGill, C.A.McMahan, A.W. Zieske, R.E. Tracy, G.T. Malcom, E.E. Herderick, et al.,
Association of coronary heart disease risk factors with microscopic qualities of
coronary atherosclerosis in youth, Circulation 102 (2000) 374–379.
[21] M. Ianni, S. Callegari, A. Rizzo, P. Pastori, P. Moruzzi, D. Corradi, et al., Pro-
inﬂammatory genetic proﬁle and familiarity of acute myocardial infarction,
Immun. Ageing 9 (2012) 14. http://dx.doi.org/10.1186/1742-4933-9-14.
[22] J.E.L. Visentainer, A.M. Sell, G.C. da Silva, A.D.G. Cavichioli, D.S.A. Franceschi, S.R.
Lieber, et al., TNF, IFNG, IL6, IL10 and TGFB1 gene polymorphisms in South and
220 J.C.P. Esperança et al. / BBA Clinical 3 (2015) 214–220Southeast Brazil, Int. J. Immunogenet. 35 (2008) 287–293. http://dx.doi.org/10.
1111/j.1744-313X.2008.00778.x.
[23] M.B. Pinheiro, K.B. Gomes, C.R.S.C. Ronda, G.G. Guimarães, L.G. Freitas, A. Teixeira-
Carvalho, et al., Severe preeclampsia: association of genes polymorphisms and
maternal cytokines production in Brazilian population, Cytokine 71 (2015)
232–237. http://dx.doi.org/10.1016/j.cyto.2014.10.021.
[24] R.G. Westendorp, J.A. Langermans, T.W. Huizinga, A.H. Elouali, C.L. Verweij, D.I.
Boomsma, et al., Genetic inﬂuence on cytokine production and fatal meningococcal
disease, Lancet 349 (1997) 170–173.
[25] D.M. Turner, D.M. Williams, D. Sankaran, M. Lazarus, P.J. Sinnott, I.V. Hutchinson, An
investigation of polymorphism in the interleukin-10 gene promoter, Eur. J.
Immunogenet. 24 (1997) 1–8.
[26] C.J. Edwards-Smith, J.R. Jonsson, D.M. Purdie, A. Bansal, C. Shorthouse, E.E. Powell,
Interleukin-10 promoter polymorphism predicts initial response of chronic
hepatitis C to interferon alfa, Hepatology 30 (1999) 526–530. http://dx.doi.org/10.
1002/hep.510300207.
[27] New polymorphisms in the interleukin-10 gene ± relationships to myocardial
infarction, 2001. 1–6.[28] G. Caligiuri, M. Rudling, V. Ollivier, M.-P. Jacob, J.-B. Michel, G.K. Hansson, et al.,
Interleukin-10 deﬁciency increases atherosclerosis, thrombosis, and low-density
lipoproteins in apolipoprotein E knockout mice, Mol. Med. 9 (2003) 10–17.
[29] W. Ambrosius, R. Kazmierski, S. Michalak, W. Kozubski, Anti-inﬂammatory
cytokines in subclinical carotid atherosclerosis, Neurology 66 (2006) 1946–1948.
http://dx.doi.org/10.1212/01.wnl.0000219808.28678.48.
[30] E. Incalcaterra, M. Caruso, C.R. Balistreri, G. Candore, R. Lo Presti, E. Hoffmann, et al.,
Role of genetic polymorphisms in myocardial infarction at young age, Clin.
Hemorheol. Microcirc. 46 (2010) 291–298. http://dx.doi.org/10.3233/CH-2010-
1353.
[31] K. Oda, N. Tanaka, T. Arai, J. Araki, Y. Song, L. Zhang, et al., Polymorphisms in pro- and
anti-inﬂammatory cytokine genes and susceptibility to atherosclerosis: a patholog-
ical study of 1503 consecutive autopsy cases, Hum. Mol. Genet. 16 (2006) 592–599.
http://dx.doi.org/10.1093/hmg/ddl483.
[32] J.-T. Chi, H.Y. Chang, G. Haraldsen, F.L. Jahnsen, O.G. Troyanskaya, D.S. Chang, et al.,
Endothelial cell diversity revealed by global expression proﬁling, Proc. Natl. Acad.
Sci. U. S. A. 100 (2003) 10623–10628. http://dx.doi.org/10.1073/pnas.1434429100.
